Innovative Pharmaceutical Biotech (HKSE:00399) Total Inventories : HK$0.00 Mil (As of Sep. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Innovative Pharmaceutical Biotech Total Inventories?

Innovative Pharmaceutical Biotech's total inventories for the quarter that ended in Sep. 2023 was HK$0.00 Mil. Innovative Pharmaceutical Biotech's average total inventories from the quarter that ended in Mar. 2023 to the quarter that ended in Sep. 2023 was HK$0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Innovative Pharmaceutical Biotech's Net-Net Working Capital per share for the quarter that ended in Sep. 2023 was HK$-1.35.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Innovative Pharmaceutical Biotech's Days Inventory for the six months ended in Sep. 2023 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Innovative Pharmaceutical Biotech's Inventory-to-Revenue for the quarter that ended in Sep. 2023 was 0.00.

Innovative Pharmaceutical Biotech Total Inventories Historical Data

The historical data trend for Innovative Pharmaceutical Biotech's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative Pharmaceutical Biotech Total Inventories Chart

Innovative Pharmaceutical Biotech Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Inventories

Get a 7-Day Free Trial

Innovative Pharmaceutical Biotech Semi-Annual Data
	Dec13	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Total Inventories	Get a 7-Day Free Trial															-	-	-	-	-

Innovative Pharmaceutical Biotech Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Innovative Pharmaceutical Biotech (HKSE:00399) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Innovative Pharmaceutical Biotech's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2023 is

	Net-Net Working Capital Per Share (Q: Sep. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.862	+	0.75 * 5.592	+	0.5 * 0	-	1049.151
-	0	-	934.525)	/	1464.19
=	-1.35

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Innovative Pharmaceutical Biotech's Days Inventory for the six months ended in Sep. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Sep. 2023 )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
	=	0	/	3.347	*	365 / 2
	=	0.00

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Innovative Pharmaceutical Biotech's Inventory Turnover for the quarter that ended in Sep. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Sep. 2023 )	/	Average Total Inventories (Q: Sep. 2023 )
	=	3.347	/	0
	=	N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Innovative Pharmaceutical Biotech's Inventory to Revenue for the quarter that ended in Sep. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	0	/	3.727
	=	0.00

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Innovative Pharmaceutical Biotech Total Inventories Related Terms

Thank you for viewing the detailed overview of Innovative Pharmaceutical Biotech's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovative Pharmaceutical Biotech (HKSE:00399) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Innovative Pharmaceutical Biotech Ltd (HKSE:00399) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

168-200 Connaught Road Central, Unit No. 2111, 21st Floor, Sheung Wan, West Tower Shun Tak Centre, Hong Kong, HKG

Website

http://www.ipb.asia

Innovative Pharmaceutical Biotech Ltd is focused on developing an insulin product that could be administered orally. It has two primary segments of business: the research and development of pharmaceutical products and the trading of beauty products. It generates maximum revenue from trading in the beauty products segment.

Innovative Pharmaceutical Biotech (HKSE:00399) Headlines

No Headlines